Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
COMPLETED
NCT06504719
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
312
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Breast Cancer
Metastatic Cancer
NOT_YET_RECRUITING
NCT07130344
PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer
262
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (NA)
Metastatic Breast Cancer
HER 2 Low-expressing Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04257162
HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a)
180
Enrollment(s)
15
Study location(s)
INTERVENTIONAL (NA)
Metastatic Cancer
NOT_YET_RECRUITING
NCT07157956
CVL006 Combination Therapy in Advanced Solid Tumors
318
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Tumor
NOT_YET_RECRUITING
NCT07151586
Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer
260
Enrollment(s)
2
Study location(s)
INTERVENTIONAL (PHASE2)
Triple Negative Breast Neoplasms
Neoplasm Metastasis
HER 2 Low-expressing Breast Cancer
RECRUITING
NCT05900206
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
370
Enrollment(s)
7
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
ACTIVE_NOT_RECRUITING
NCT05660135
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
4,000
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Hypertension
Dyslipidemias
ACTIVE_NOT_RECRUITING
NCT05411887
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
2,845
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Hyperlipidemias
Hypertension
26
27
28
29
30